Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Knowing when to modify your financial plan is essential for optimal results. Discover key indicators that signal it's time for adjustments.
23,050 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A sharp rise in Alumis shares coincides with a fresh stake from Cormorant Asset Management. This article breaks down ...
A major investor stepped into Crocs with a sizable new stake, valuing the position at about $53.7 million even as CRO...
As markets swing in May 2026, PJUL caps your gains at a defined ceiling while protecting against early losses, a path...
Nu Holdings has shown impressive growth, but the true challenge lies in weathering a credit cycle. This guide explain...
When markets wobble, the strength of a company’s balance sheet and its cash runway often beat a glossy business story...
A new funding framework is here. The housing 21st century brings new loan options and smarter ways to build and prese...
In May, iren limited rallied almost 40% as investors priced in AI growth, earnings signals, and a new Nvidia partners...
Looking to find a better space stock: spacemobile? This guide breaks down AST SpaceMobile and Rocket Lab, weighing te...
ServiceNow is rolling out an AI-driven strategy that aims to turn it into a central control tower for enterprise work...
A major gaming operator dominates the spotlight with $11.5 billion in revenue, while a $16 million institutional exit...
Midday trading shows inflation fears and global tensions pressing equities. This update breaks down what’s moving the...